Litcius/Paper detail

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

Lu Zhang, Amy Kempf, Inga Nehlmeier, Anne Cossmann, Anja Richter, Najat Bdeir, Luise Graichen, Anna-Sophie Moldenhauer, Alexandra Dopfer‐Jablonka, Metodi V. Stankov, Etienne Simon‐Lorière, Sebastian Schulz, Hans‐Martin Jäck, Luka Čičin‐Šain, Georg M. N. Behrens, Christian Drosten, Markus Hoffmann, Stefan Pöhlmann

2024Cell121 citationsDOIOpen Access PDF

Topics & Concepts

BiologyInfectivityVirologyAntibodyNeutralizationVirusProteasesNeutralizing antibodyViral entryCoronavirusImmunologyCoronavirus disease 2019 (COVID-19)Viral replicationPathologyEnzymeInfectious disease (medical specialty)BiochemistryDiseaseMedicineSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency | Litcius